Compare JBGS & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBGS | STAA |
|---|---|---|
| Founded | 2016 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Ophthalmic Goods |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2017 | N/A |
| Metric | JBGS | STAA |
|---|---|---|
| Price | $18.04 | $25.91 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 2 | 8 |
| Target Price | $16.50 | ★ $22.50 |
| AVG Volume (30 Days) | 722.3K | ★ 798.5K |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.89% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $501,226,000.00 | $230,591,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.79 | $26.88 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.28 | $13.50 |
| 52 Week High | $24.30 | $30.81 |
| Indicator | JBGS | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 40.29 | 46.75 |
| Support Level | $17.36 | $25.87 |
| Resistance Level | $18.69 | $28.40 |
| Average True Range (ATR) | 0.58 | 0.98 |
| MACD | 0.14 | -0.05 |
| Stochastic Oscillator | 60.69 | 21.27 |
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party asset management and real estate services. It generates maximum revenue from the commercial segment.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.